Figure 1. Velagliflozin (Senvelgo) is marketed as a solution for oral administration. It does not require any changes in dose, specific feeding times or glucose monitoring. It can produce diarrhoea in the first two to three weeks and careful monitoring for ketosis is important.

Sodium-glucose co-transporter 2 inhibitor treatment in diabetic cats

Cats with diabetes mellitus typically experience a condition that is comparable to type 2 diabetes in humans, and is characterised by relative insulin deficiency and insulin resistance (Gostelow and...